Wang et al. showed that genetically engineered upregulation of long non-coding RNA 135528 (Lnc135528) promotes tumor regression by upregulating CXCL10 and the JAK/STAT signaling pathway in vivo [83]. This evidence concerns the gene CXCL10 and neoplasm.